Clinical Trial Update: Alterations of Immunologic Mediators During Severe Sepsis

View source ↗

Summary

A clinical trial investigating alterations of immunologic mediators in patients with severe sepsis; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Klinikum St. Georg gGmbH | Conditions: Severe Sepsis | Status: TERMINATED